Please assess the completion status of the following clinical trial:

Trial Title: Renal Denervation in Patients With Chronic Heart Failure & Renal Impairment Clinical Trial

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Heart Failure patients NYHA Class II or III~* Renal Impairment Left Ventricular Ejection Function \<40%~* GFR 30 to 75 mL/min/1.73m2~* Optimal stable medical therapy~Exclusion Criteria:~* Renal artery anatomy must be eligible for treatment as determined by Angiography, and~* History of prior renal artery intervention~* Single functioning kidney.~* Myocardial Infarction, unstable angina pectoris or cerebrovascular Accident within 3 months~* Systolic BP \< 90 mmHG

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single arm (Type: OTHER): Renal Denervation

Based on this trial design, predict the completion outcome and termination type (if applicable).